A possible explanation for dizziness following SSRI discontinuation

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Dizziness is a common symptom upon abrupt discontinuation of selective serotonin reuptake inhibitors (SSRIs).
• This dizziness is often exacerbated by head movements, suggesting a vestibular origin.
• SSRIs with short half-lives and high serotonin selectivity, like paroxetine and sertraline, are most implicated.

Purpose of the Study:

• To investigate the neurophysiological basis of dizziness experienced during SSRI withdrawal.
• To propose a mechanism involving the vestibular nucleus complex (VNC) and serotonin levels.

Main Methods:

• The study suggests a theoretical model based on the known neuroanatomy and neurochemistry of the VNC.
• It highlights the role of serotonin receptors in the VNC and their interaction with SSRIs.

Main Results:

• Abrupt SSRI withdrawal leads to a sudden decrease in serotonin within the VNC.
• This decrease disrupts the electrophysiological activity of VNC neurons bilaterally.
• The disruption causes dizziness without associated vertigo.

Conclusions:

• The findings suggest that SSRI-induced dizziness is a direct consequence of altered serotonin neurotransmission in the vestibular system.
• Understanding this mechanism can inform clinical management of antidepressant discontinuation symptoms.